The Debrief1d
The Promise and Peril of Gene Editing
In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...
News Medical2d
Researchers launch startup to revolutionize targeted drug delivery using milk exosomes
Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...
New Atlas2d
Got milk? Startup develops milk-based targeted drug-delivery technology
A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an ...
CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
An Entire Book Was Written in DNA—and You Can Buy It for $60
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular ...
Beam Therapeutics' SWOT analysis: gene editing pioneer's stock faces crucial clinical milestones
Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...